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Abstract
Previously we have shown that a functional nonsynonymous single nucleotide polymorphism (rs6318) of the 5HTR2C gene
located on the X-chromosome is associated with hypothalamic-pituitary-adrenal axis response to a stress recall task, and
with endophenotypes associated with cardiovascular disease (CVD). These findings suggest that individuals carrying the
rs6318 Ser23 C allele will be at higher risk for CVD compared to Cys23 G allele carriers. The present study examined allelic
variation in rs6318 as a predictor of coronary artery disease (CAD) severity and a composite endpoint of all-cause mortality
or myocardial infarction (MI) among Caucasian participants consecutively recruited through the cardiac catheterization
laboratory at Duke University Hospital (Durham, NC) as part of the CATHGEN biorepository. Study population consisted of
6,126 Caucasian participants (4,036 [65.9%] males and 2,090 [34.1%] females). A total of 1,769 events occurred (1,544 deaths
and 225 MIs; median follow-up time= 5.3 years, interquartile range = 3.3–8.2). Unadjusted Cox time-to-event regression
models showed, compared to Cys23 G carriers, males hemizygous for Ser23 C and females homozygous for Ser23C were at
increased risk for the composite endpoint of all-cause death or MI: Hazard Ratio (HR) = 1.47, 95% confidence interval (CI)
= 1.17, 1.84, p = .0008. Adjusting for age, rs6318 genotype was not related to body mass index, diabetes, hypertension,
dyslipidemia, smoking history, number of diseased coronary arteries, or left ventricular ejection fraction in either males or
females. After adjustment for these covariates the estimate for the two Ser23 C groups was modestly attenuated, but
remained statistically significant: HR = 1.38, 95% CI = 1.10, 1.73, p = .005. These findings suggest that this functional
polymorphism of the 5HTR2C gene is associated with increased risk for CVD mortality and morbidity, but this association is
apparently not explained by the association of rs6318 with traditional risk factors or conventional markers of atherosclerotic
disease.
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Introduction
It has been proposed [1] that one way genes influence the
development and course of coronary heart disease (CHD) is via
moderation of the effects of environmental stressors on brain
mechanisms that regulate expression of behavioral and biological
endophenotypes that are proximately involved in cardiovascular
disease (CVD) pathogenesis and the precipitation of clinical CVD
events. The X chromosome gene encoding the serotonin 2C
receptor (5HTR2C) is an attractive candidate to be playing such a
role. This receptor plays a key role in mediation of stress-induced
hypothalamic-pituitary-adrenal (HPA) axis activation by stress-
induced release of serotonin in the central nervous system (CNS)
[2,3,4], leading to attempts to identify variants in the 5HTR2C
gene that might moderate the HPA axis response to psychological
stress. One such 5HTR2C variant that has received considerable
attention is a coding nonsynonymous single nucleotide polymor-
phism (SNP) – rs6318; 68G.C – which leads to a substitution of
serine for cysteine at codon 23 (Cys23Ser). The frequency of the
Ser23 C allele is approximately 13% in unrelated Caucasians [5].
Research indicates that the Ser23 C allele is constitutively more
active than the Cys23 G allele [6], with allele-specific analysis of
receptor function showing functional differences in the activity of
the Ser23 minor allele relative to the Cys23 allele.
Male carriers of the less common Ser23 C allele show a trend
toward faster and stronger adrenocorticotropic hormone ACTH
responses to the 5HTR2C agonist m-chlorophenylpiperazine (m-
CPP) [7], as well as a different pattern of change in regional
cerebral blood flow following m-CPP infusion compared to men
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carrying the 5HTR2C Cys23 G allele [8]. In related work [9] we
recently found that rs6318 was associated with stress responses to
an emotional stress task in the laboratory. Specifically, in a sample
of males, Ser23 C allele carriers had two-fold larger increases in
both plasma cortisol and subjective ratings of negative emotion
during recall of situations that made them angry or sad compared
to those carrying the Cys23 G allele. This finding corroborated
existing evidence that the 5HTR2C receptor plays a key role in the
activation of the HPA axis by acute stress, and is consistent with
prior research [6] showing the Ser23 C allele is constitutively more
active than the Cys23 G allele.
Other findings indicate that individuals carrying the 5HTR2C
Ser23 C allele will be more likely than Cys23 G allele carriers to
express elevated levels of phenotypes associated with elevated
cortisol levels -- central obesity, elevated glucose, insulin and
insulin resistance, higher blood pressure and lipids, hypertension,
type-2 diabetes, coronary heart disease [10,11]. Our prior work
has also shown that individuals carrying the 5HTR2C Ser23 C
allele are more likely than Cys23 G allele carriers to exhibit
metabolic profiles that are related to increased risk levels of CVD
(i.e., higher central obesity, poorer glucose metabolism, higher
levels of serum lipids). Specifically, in a sample of 243 males and
259 homozygous (C/C vs. G/G) females we found that compared
to G allele carriers, C allele carriers who were 30 years of age or
older had higher levels of HbA1c and higher hip circumference,
total body fat, and trunk fat composition [12]. In addition,
irrespective of age, C allele carriers had significantly poorer lipid
profiles.
Finally, chronically increased HPA axis function, indexed by
elevated hair cortisol levels, has been associated with increased risk
of myocardial infarction (MI) in men [13]. Moreover, increased
levels of coronary artery calcification have been documented in
men and women with larger salivary cortisol responses to mental
stress [14]. Based on our model positing that genes influence the
development and course of CHD via moderation of stress effects
on brain mechanisms that regulate expression of CHD endophe-
notypes [1] and the evidence reviewed above, we hypothesized
that the rs6318 Ser23 C variant would be associated with
increased severity of coronary artery disease (CAD) and incidence
of CVD mortality and morbidity in a sample of 6,126 Caucasian
individuals recruited through the cardiac catheterization labora-
tory at Duke University Hospital (Durham, NC).
Methods
Participants
The collection of CATHeterization GENetics (CATHGEN)
subjects has been described elsewhere [15,16,17]. Briefly, CATH-
GEN study participants were recruited through the cardiac
catheterization laboratories at Duke University Hospital (Durham,
NC, USA), with approval from the Duke Institutional Review
Board, and all participants signed informed consent. Although the
CATHGEN study is comprised a variety of ethnic groups,
the majority of subjects are Caucasian (75.0%). To avoid the
confounding effects of population stratification while maximizing
our power to detect genetic associations, we chose to analyze the
Caucasian participants only. As part of the ongoing follow-up of
the Duke Databank for Cardiovascular Diseases (DDCD),
CATHGEN participants are surveyed annually for cardiovascular
disease and the participant list is compared to the National Death
Index. Events were defined as death from any cause and/or MI,
and they were followed for up to 11.8 years.
Measures
Genotyping. Genomic DNA was extracted from frozen whole
blood samples collected from the participants during cardiac
catheterization. SNP was genotyped using Taqman genotyping
assay (Life Technologies) and the Type-It Fast Probe PCR kit
(Qiagen). For each 5 ml reaction a solution containing 2 ml Type-It
Fast Probe PCR Master Mix (Qiagen), 0.05 ml 80x Taqman assay
(Life Technologies), and 0.5 ml Q-solution (Qiagen) was added to 3
ng of dried DNA template. The temperature program was 95uC
for 5 minutes, then 50 cycles of 95uC for 15 seconds and 60uC for
30 seconds, run on the GeneAmp PCR system 9700 (Life
Technologies). Fluorescence was read and analyzed on the ViiA 7
instrument (Life Technologies). PCR reactions were performed in
384 well format with 4 negative controls. SNP genotype call rate
was above 95%. Due to the SNP on X chromosome the deviation
from Hardy-Weinberg equilibrium was tested only in females, and
no such deviation was observed (p= 0.505).
Risk factors. Body mass index (BMI), and binary indicators of
history of cigarette smoking, dyslipidemia, hypertension, and
history of diabetes were all assessed at the time of cardiac
catheterization, i.e., at the beginning of the study.
Disease Severity: Number of diseased vessels and left
ventricular ejection fraction. Severity of CAD was deter-
mined as an ordinal variable defined as the number of vessels with
significant ($75%) stenosis as determined by the interventional
cardiologist performing the procedure. A higher number of
diseased vessels (0–3) indicate greater disease severity. Left
Ventricular Ejection Fraction (LVEF) is expressed as the
percentage of blood pumped out of the left ventricle on systole.
LVEF was measured either during cardiac catheterization, or
chart review for an echocardiogram, nuclear study or cardiac MRI
done within 1 year on either side of the catheterization.
Statistical Analyses
We first compared genotypes within each sex on demographic,
risk factor, and disease marker variables using linear, logistic or
ordinal logistic regression, depending on the measurement
characteristics of the response variable. Cox regression models
were estimated using a composite of time to all-cause death or
verified MI as the response variable. Participants who were lost to
follow-up or who had not experienced an event by the last date of
follow-up were coded as censored in the analysis. SAS version 9.1
(Cary, NC) and the rms package in R (http://cran-rproject.org)
were used for all analyses. Because rs6318 is X-linked, for the
purpose of analysis we created a five-level categorical ‘‘Sex-
Genotype’’ variable for each combination of sex and genotype
(male Ser23 C hemizygotes, male Cys23 G hemizygotes, female
Ser23 C homozygotes, female heterozygotes, and female Cys23 G
homozygotes). This approach facilitated testing the contrasts of
interest, which were: 1) hemizygous Ser23 C males and
homozygous Ser23 females versus all Cys23 G carriers; 2) male
Ser23 C hemizygotes versus male Cys23 G hemizygotes; 3) female
Ser23 C homozygotes vs. female Cys23 G carriers; 4) males versus
females. We estimated these contrasts first unadjusted and then
adjusted for age, sex, BMI, history of smoking, history of diabetes,
history of dyslipidemia, history of hypertension, LVEF, and
number of diseased vessels. The proportional hazards assumption
was met for all models. A small fraction of cases (0.4%) were
missing a measure of BMI and a larger portion (9.9%) were
missing a measure of LVEF. In the Cox models, we conducted
preliminary analyses comparing multiple imputation with single
median imputation for managing these missing cases and found no
material difference in the results. We therefore present the results
of the models using single median imputation here.
5HTR2C Gene and CVD
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Results
The clinical characteristics of the CATHGEN study population
used in this study are presented for Ser23 C and Cys23 G allele
carriers in Table 1, stratified by sex. Variation in rs6318 was not
related to any of the demographic, CVD risk, or CVD marker
variables. There were a total of 1,544 deaths and 225 non-fatal
MIs, totaling to 1,769 clinical events, over a median follow-up time
of 5.9 years (interquartile range = 3.3–8.2). The proportion of
individuals experiencing clinical events was highest among male
Ser23 C hemizygotes (246/700= 35.1%) and female Ser23 C
homozygotes (23/63= 36.5%), compared to male Cys23 G
hemizygotes (963/3336= 28.9%), female Cys23 G homozygotes
(392/1455= 26.9%), and female heterozygotes (145/572=
25.4%).
Unadjusted Kaplan-Meier survival curves for each genotype are
presented in Figure 1, separately for each sex (panel a for females,
panel b for males). Parallel to the raw event frequency counts,
male Ser23 C hemizygotes and female Ser23 C homozygotes
showed the most rapid time-to-event rates. These differences in
event rates were quantified in the Cox regression models using the
entire sample of males and females simultaneously. Table 2
displays the results of each group contrast in the unadjusted and
adjusted Cox regression models. In the unadjusted Cox model
(columns 1 through 3 in Table 2), compared to all Cys23 G
carriers (males hemizygous for Cys23 G, females homozygous for
Cys23 G, heterozygous females), hemizygous Ser23 C males and
homozygous Ser23C females were at increased risk for the
composite clinical endpoint of all-cause death or MI: Hazard
Ratio (HR) = 1.47, 95% confidence interval (CI) = 1.17, 1.84,
p = .0008. After adjustment for age, BMI, diabetes, hypertension,
dyslipidemia, smoking history, number of diseased coronary
arteries, and LVEF, the estimate for the two Ser23 C groups
was modestly attenuated, but remained statistically significant:
HR=1.38, 95% CI= 1.10, 1.73, p = .005. Examining contrasts
within each sex showed that the increased risk associated with the
Ser23 C allele was present for both men and women, but tended to
be somewhat larger for women. The hazard ratio from the fully
adjusted model for male Ser23 C hemizygotes compared to male
Cys23 G hemizygotes was 1.23 (95% CI= 1.02, 1.36, p = 0.02),
while the hazard ratio for female Cys23 C homozygotes versus
female Cys23 G carriers was 1.62 (95% CI= 1.07, 2.47, p = 0.02).
In both cases the unadjusted estimates were modestly attenuated
after adjustment for the covariates. No effect for sex per se was
observed in either adjusted or unadjusted analysis.
With the exception of history of hypertension, all of the
adjustment covariates were associated with the composite
endpoint in the fully adjusted Cox regression model (see Table
2, columns 4 through 6). Older age, history of smoking, history of
diabetes, and a higher number of coronary arteries were associated
with increased rates of events, while higher BMI, higher left
ventricular ejection fraction, and history of dyslipidemia were
associated with a lower risk of events.
Discussion
We have found herein that a functional coding polymorphism in
5HTR2C, previously associated with enhanced cortisol response to
psychosocial stress and intermediate CVD phenotypes, is also
associated with a 38% increase in ‘‘end’’ CVD events over a 7-
year follow-up period, supporting our hypothesis that mapping of
intermediate traits can identify novel CVD genes. However, the
status of our hypothesis that the association between Ser23 C and
clinical events would be mediated by CVD risk factors or markers
of clinical disease is less clear. On one hand, adjustment for these
potential mediating variables resulted in modest attenuation of the
hazard estimates for Ser23 C, suggesting the possibility of
mediation by these variables. On the other hand, however, the
lack of direct association between genotype and these potential
mediators argues against this interpretation. One possible expla-
nation for this apparent paradox is that the putative mediating
variables have an aggregate effect that is not detectable when
considering them individually. For example, in males Ser23 C was
associated with a slight increase in the frequency of having three
vessel CAD and having a history of diabetes, but neither test met
the conventional significance criterion of 0.05. In addition, our risk
factor variables were indicators of a history of those risk factors
rather than direct measures of the risk factors themselves. Since
this was a clinical population, many participants may already have
been treated for these risk factors, limiting the precision of the
history variables as indicators of risk. For example, individuals
with histories of dyslipidemia or hypertension may in part be
proxies for treatment for these conditions, obscuring the associ-
ation between these risk factors and the endpoint. Of more
certainty is that the persistence of the association between Ser23 C
and clinical events even after adjustment suggests the involvement
of mechanisms other than those measured in the present study.
Enhanced HPA axis response to stress in Ser23 C carriers is one
potential candidate mechanism. In our earlier work, we showed
that men carrying the Ser23 C allele exhibited larger increases in
both HPA axis function as measured by serum cortisol and
subjective ratings of anger/sadness in a laboratory setting. In our
initial study [9] females were not included due to the low cell
counts, with only three women homozygous for the C allele and 16
homozygous for the G allele. Given the relevance of the findings
for women in the present study, however, we re-examined the
data, now comparing cortisol levels in response to the stress
protocol across genotypes. We found that, parallel to the finding in
original finding in men, CC women showed larger cortisol
response than the GG women (p ,.047).
These findings are consistent with the known function of
5HT2C receptors in the hypothalamic paraventricular nucleus
(PVN), suggesting that corticotropin-releasing hormone (CRH),
when stimulated by serotonin, may be mediating an increase in
both HPA axis function and angry and sad moods [9]. In turn,
chronic release of endogenous cortisol may be an independent risk
factor for cardiovascular clinical events. For example, Pereg et al.
[13] recently reported that hair cortisol levels were strongly
associated with acute myocardial infarction (OR=OR 17.4, 95%
CI= 2.15, 140.45, p = 0.007) even after adjusting for age, LDL
and HDL cholesterol, BMI, smoking status, and previous MI. The
authors speculate that the association might be owing to the
known effects of cortisol on endothelial function, platelet
aggregation, inflammation, or promotion of thrombotic events
(see [13], p. 77). Among these potential links between cortisol and
clinical events, inflammation may be particularly promising, owing
to a recently discovered set of connections from cortisol to unstable
atherosclerotic plaque in the coronary arteries. Briefly, unstable
plaques are lesions in the vessel endothelium characterized by a
lipid-rich core surrounded by a friable cap of connective tissue. As
the name implies, vulnerable plaque is easily disrupted by sudden
changes in pressure or torsion within the vessel. When the fibrous
cap is broken, the lipid content of the plaque is released into the
vessel lumen, resulting in thrombus and setting the stage for
possible infarction. Several studies have shown that increased
cortisol is associated with increased levels of a collagen-degrading
protein called matrix metalloproteinase (MMP-9) [18,19]. MMP-9
in turn has been causally implicated in the development of
vulnerable plaque [20]. As noted earlier, rs6318 appears to
5HTR2C Gene and CVD
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regulate secretion of cortisol. Thus, a possible, if highly simplified,
pathway linking rs6318 to cardiac events may be gene R cortisol
R MMP-9 R vulnerable plaque R clinical event. Finally, fatal
cardiac arrhythmias also may be a potential mediating mecha-
nism. At present however, we are unaware of a biological link
between rs6318 and arrhythmias, nor does our own data set
include reliable information on arrhythmias.
Indeed, HPA axis hyperreactivity is regularly cited as a potential
mediator of psychosocial risk factors’ health-damaging effects. For
example, high levels of hostility have been associated with
increased cortisol responses to anger-inducing interpersonal
challenge [21], and increased stress in daily life is associated with
a higher cortisol awakening response and higher mean day and
evening cortisol levels [22]. Investigation of the neurobiological
Figure 1. Kaplan-Meier curves illustrating the risk of death or myocardial infarction for each rs6318 genotype in Women (panel a)
and Men (panel b). Using pre-specified contrasts in a Cox regression model adjusted for covariates, differences were statistically significant when
comparing: male Ser23 C hemizygotes and female Ser23 C homozygotes to all Cys23 G carriers (p = .005); male Ser23 C hemizygotes to male Cys23 G
hemizygotes (p = .022), and female Ser23 C homozygotes to female Cys23 G carriers (p = .024).
doi:10.1371/journal.pone.0082781.g001
Table 2. Cox regression models predicting death or non-fatal myocardial infarction (N = 6,126, N events = 1,769).
Unadjusted Model Model Including Adjustment Covariates
Contrast Hazard Ratio
95% Confidence
Interval p-value Hazard Ratio
95% Confidence
Interval p-value
Male Ser23 C hemizygotes and Female Ser23 C
homozygotes vs. all Cys23 G carriers
1.47 1.17, 1.84 .0008 1.38 1.10, 1.73 .005
Male Ser23 C hemizygotes vs. Male Cys23 G
hemizygotes
1.23 1.07, 1.42 .004 1.18 1.02, 1.36 .022
Female Ser23 C homozygotes vs. Female Cys23 G
carriers
1.68 1.11, 2.56 .015 1.62 1.07, 2.47 .024
All Males vs. all Females 1.05 0.98, 1.24 .556 0.92 0.77, 1.09 .312
Age (per 10 year increase) -- -- -- 1.47 1.40, 1.54 ,.0001
Body Mass Index (per 7 kg/m2 increase) -- -- -- 0.93 0.87, 0.98 ,.009
History of Smoking -- -- -- 1.40 1.27, 1.54 ,.0001
History of Dyslipidemia -- -- -- 0.75 0.68, 0.83 ,.0001
History of Hypertension -- -- -- 1.04 0.93, 1.16 ,.485
History of Diabetes -- -- -- 1.49 1.34, 1.66 ,.0001
Number of coronary arteries with $ 75% stenosis
(per one artery increase)
-- -- -- 1.14 1.09, 1.19 ,.0001
Left Ventricular Ejection Fraction (per 15% increase) -- -- -- 0.74 0.70, 0.78 ,.0001
Note: The model including adjustment covariates included all predictors simultaneously.
doi:10.1371/journal.pone.0082781.t002
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mechanisms by which psychosocial risk factors enhance the
activity of the HPA axis indicates that stress-induced release of
serotonin in the CNS acts at multiple brain sites to contribute to
stress-induced HPA axis activation. These sites include the limbic
forebrain including the amygdala, where serotonin stimulates
5HTR2C receptors on cells in the paraventricular nucleus (PVN),
that co-express corticotrophin releasing hormone (CRH), which is
released when the 5HTR2C receptors are stimulated [2,3,4]. Thus,
the Ser23 C allele’s association with increased cortisol response to
emotional stress provides a biologically plausible path that could
be responsible for the association we found in this large CVD
sample between the Ser23 C allele, possibly by way of CAD
severity, but also by way of other mechanisms not captured in our
present study.
In addition to its association with enhanced activation of the
HPA axis and larger increases in anger and sadness during
emotion arousal in the laboratory in our prior study [9], the Ser23
C variant has also been found to be associated with affective
disorders [23]. Specifically, in a sample consisting of European
populations, there were significantly larger proportions of Ser23 C
allele carriers in patients with major depressive and bipolar
disorder, as compared to normal controls [23]. Depression has
long been linked to dysregulated HPA axis function, and depressed
men exhibit higher levels of salivary cortisol across the day
compared to healthy men [24]. The present findings, along with
studies linking the Ser23 C allele with affective disorders, suggest,
therefore, that the rs6318 moderation of 5HT2C receptor-
mediated effects on both emotions and the HPA axis may be
accounting, at least in part, for the previously reported linkages
between depression and dysregulated HPA axis function.
Importantly, increased HPA activation by stress has also been
implicated in the impact of stress on the pathogenesis of the
metabolic syndrome [25], and elevated cortisol levels have been
shown to play a role in mediating the association between
depressive symptoms and elevated blood glucose levels [26].
Furthermore, prospective studies provide direct evidence for a
causal role in that glucocorticoid excess predicts increased
cardiovascular disease (CVD) incidence [27,28] and elevated
cortisol levels have also been found associated with several indices
of accelerated aging, including decreased bone mineral density
[29], increased incident cognitive impairment [30] and increased
frailty[31]. Finally, as noted earlier, we have shown that the Ser23
C allele has been associated with poorer metabolic profiles [12].
Our present analyses, however, showed no association between
Ser23 C with BMI, dyslipidemia, or hypertension, three correlates
of metabolic syndrome. Again, it may be that because this was a
clinical population, participants with dyslipidemia or hypertension
may have been adequately treated, thus attenuating any associ-
ation with these variables. The unique nature of the clinical
sample also may be reflected in our observation that history of
dyslipidemia and a higher BMI were associated with lower event
rates. The unexpected direction of these associations may be a
function of adequate treatment for dyslipidemia, or in the case of
BMI, excessively low BMI indicating cachexia and advanced
disease.
The current findings have potentially important implications for
the development of targeted preventive interventions and treat-
ments. It has been shown, for example, that cognitive behavioral
stress management training produces reduced anxiety and cortisol
levels that are maintained over a 12-month follow-up period in
women undergoing treatment for breast cancer [32]. A more
direct clinical implication of the current findings is that persons
carrying the 5HTR2C rs6318 Ser23C allele might benefit from
treatment with an antagonist of the 5HTR2C receptor. One such
antagonist that has received extensive clinical attention is
agomelatine (trade names Valdoxan, Melitor, Thymanax), a
melatonergic agonist and 5-HT2C antagonist that has higher
efficacy than sertraline in reducing both depressive and anxiety
symptoms in depressed patients [33]. Of direct relevance to the
current findings, agomelatine has been found to reduce the
elevated HPA axis activity produced by psychosocial stress in tree
shrews [34]. In healthy older men agomelatine treatment was
associated with a lower peak cortisol level reached during the
morning hours [35]. It is possible therefore, that treatment with
agomelatine could be effective in reducing mortality/MI risk in
CHD patients carrying the rs6318 Ser23C allele.
An important limitation of the current study is the fact that this
is an association study, as opposed to an experimental design with
a direct manipulation. However, it should be noted that our
theoretical model and the accumulation of specific findings for the
rs6318 Ser23 C allele led to a targeted a priori hypothesis that was
supported in a large clinical sample. Future work should include
attempts at direct replication of the present finding, as well as
continued elucidation of the underlying biological mechanisms. In
that respect, the currently available evidence for a functional
consequence of this SNP comes from reports of differential
5HTR2C function comparing the amino acid substitution of
Serine for Cysteine at position 23 [6,7,8]. Surveys of available
expression quantitative trait loci (eQTL) databases did not,
however, identify significant effects of this SNP on gene expression
and we found no literature reports of a regulatory role for this SNP
on gene expression. Besides effects on gene expression, another
possible mechanism that could account for the effects of the rs6318
C allele on the function of the 5HTR2C receptor that increase
cortisol responses to stress (and thereby affect clinical outcomes
in CHD patients) is that substitution of serine for a cysteine residue
in 5HTR2C protein among C allele carriers could result in
disruption of disulfide bridges that play a critical role in the folding
of a protein into its native conformation [36]. More research,
beyond the scope of this report, will be required to determine
whether protein structure and folding varies as a function of
rs6318 genotype. Finally, the present findings were limited to
Caucasian participants and may not generalize to populations of
other ethnicities.
In conclusion, we found that a previously documented
functional SNP, rs6318, on the 5HTR2C gene that has been
previously associated with increased cortisol response to stress,
depression, and metabolic traits linked to CVD, was associated
with increased incidence of death or MI, independent of several
traditional risk factors and two conventional markers of CVD
severity in a large sample of Caucasian patients. If replicated in
further research, these findings suggest that behavioral and
pharmacologic interventions to reduce HPA axis hyperreactivity
in rs6318 Ser23C allele carriers deserve attention as a means of
improving CVD-related prognosis in patients, and ultimately in
primary prevention.
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